Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 746

1.

The three-year incidence of pulmonary arterial hypertension associated with systemic sclerosis in a multicenter nationwide longitudinal study in France.

Hachulla E, de Groote P, Gressin V, Sibilia J, Diot E, Carpentier P, Mouthon L, Hatron PY, Jego P, Allanore Y, Tiev KP, Agard C, Cosnes A, Cirstea D, Constans J, Farge D, Viallard JF, Harle JR, Patat F, Imbert B, Kahan A, Cabane J, Clerson P, Guillevin L, Humbert M; Itinér AIR-Sclérodermie Study Group.

Arthritis Rheum. 2009 Jun;60(6):1831-9. doi: 10.1002/art.24525.

2.

Early detection of pulmonary arterial hypertension in systemic sclerosis: a French nationwide prospective multicenter study.

Hachulla E, Gressin V, Guillevin L, Carpentier P, Diot E, Sibilia J, Kahan A, Cabane J, Francès C, Launay D, Mouthon L, Allanore Y, Tiev KP, Clerson P, de Groote P, Humbert M.

Arthritis Rheum. 2005 Dec;52(12):3792-800.

3.

Role of N-terminal brain natriuretic peptide (N-TproBNP) in scleroderma-associated pulmonary arterial hypertension.

Williams MH, Handler CE, Akram R, Smith CJ, Das C, Smee J, Nair D, Denton CP, Black CM, Coghlan JG.

Eur Heart J. 2006 Jun;27(12):1485-94. Epub 2006 Apr 27.

PMID:
16682379
4.

Comparison of Doppler echocardiography and right heart catheterization to assess pulmonary hypertension in systemic sclerosis.

Denton CP, Cailes JB, Phillips GD, Wells AU, Black CM, Bois RM.

Br J Rheumatol. 1997 Feb;36(2):239-43.

PMID:
9133938
6.

High N-terminal pro-brain natriuretic peptide levels and low diffusing capacity for carbon monoxide as independent predictors of the occurrence of precapillary pulmonary arterial hypertension in patients with systemic sclerosis.

Allanore Y, Borderie D, Avouac J, Zerkak D, Meune C, Hachulla E, Mouthon L, Guillevin L, Meyer O, Ekindjian OG, Weber S, Kahan A.

Arthritis Rheum. 2008 Jan;58(1):284-91. doi: 10.1002/art.23187.

7.

Assessment of pulmonary arterial hypertension in patients with systemic sclerosis: comparison of noninvasive tests with results of right-heart catheterization.

Hsu VM, Moreyra AE, Wilson AC, Shinnar M, Shindler DM, Wilson JE, Desai A, Seibold JR.

J Rheumatol. 2008 Mar;35(3):458-65. Epub 2008 Jan 15.

PMID:
18203320
8.

Assessment for Pulmonary Artery Hypertension Using Clinical and Echocardiographic Criteria in Patients With Systemic Sclerosis.

Methia N, Latreche S, Ait Mokhtar O, Monsuez JJ, Benkhedda S.

Am J Med Sci. 2016 Oct;352(4):343-347. doi: 10.1016/j.amjms.2016.07.007. Epub 2016 Jul 16.

PMID:
27776714
9.

Ventricular mass index correlates with pulmonary artery pressure and predicts survival in suspected systemic sclerosis-associated pulmonary arterial hypertension.

Hagger D, Condliffe R, Woodhouse N, Elliot CA, Armstrong IJ, Davies C, Hill C, Akil M, Wild JM, Kiely DG.

Rheumatology (Oxford). 2009 Sep;48(9):1137-42. doi: 10.1093/rheumatology/kep187. Epub 2009 Jul 14.

PMID:
19605369
10.

Screening for pulmonary arterial hypertension in patients with systemic sclerosis: clinical characteristics at diagnosis and long-term survival.

Humbert M, Yaici A, de Groote P, Montani D, Sitbon O, Launay D, Gressin V, Guillevin L, Clerson P, Simonneau G, Hachulla E.

Arthritis Rheum. 2011 Nov;63(11):3522-30. doi: 10.1002/art.30541.

11.

Determinants of pulmonary arterial hypertension in scleroderma.

Plastiras SC, Karadimitrakis SP, Kampolis C, Moutsopoulos HM, Tzelepis GE.

Semin Arthritis Rheum. 2007 Jun;36(6):392-6. Epub 2007 Jan 3.

PMID:
17204309
12.

Exercise Doppler echocardiography identifies preclinic asymptomatic pulmonary hypertension in systemic sclerosis.

Pignone A, Mori F, Pieri F, Oddo A, Galeota G, Fiori G, Del Rosso A, Perfetto F, Becucci A, Livi R, Tempestini A, Benvenuti C, Gramigna L, Fedi R, Generini S, Minelli M, Cinelli M, Guiducci S, Arcangeli C, Conforti ML, Bernardo P, Cerinic MM.

Ann N Y Acad Sci. 2007 Jun;1108:291-304.

PMID:
17893993
13.

Prevalence of exercise pulmonary arterial hypertension in scleroderma.

Callejas-Rubio JL, Moreno-Escobar E, de la Fuente PM, Pérez LL, Fernández RR, Sánchez-Cano D, Mora JP, Ortego-Centeno N.

J Rheumatol. 2008 Sep;35(9):1812-6. Epub 2008 Jul 15.

PMID:
18634147
14.

Ethnic disparities among patients with pulmonary hypertension associated with systemic sclerosis.

Beall AD, Nietert PJ, Taylor MH, Mitchell HC, Shaftman SR, Silver RM, Smith EA, Bolster MB.

J Rheumatol. 2007 Jun;34(6):1277-82. Epub 2007 May 15.

PMID:
17516621
15.

Systemic sclerosis-related pulmonary hypertension associated with interstitial lung disease: impact of pulmonary arterial hypertension therapies.

Le Pavec J, Girgis RE, Lechtzin N, Mathai SC, Launay D, Hummers LK, Zaiman A, Sitbon O, Simonneau G, Humbert M, Hassoun PM.

Arthritis Rheum. 2011 Aug;63(8):2456-64. doi: 10.1002/art.30423.

16.

The presence of anti-centromere antibodies may predict progression of estimated pulmonary arterial systolic pressure in systemic sclerosis.

Kampolis C, Plastiras S, Vlachoyiannopoulos P, Moyssakis I, Tzelepis G.

Scand J Rheumatol. 2008 Jul-Aug;37(4):278-83. doi: 10.1080/03009740801978871.

PMID:
18612928
17.

Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach.

Mukerjee D, St George D, Coleiro B, Knight C, Denton CP, Davar J, Black CM, Coghlan JG.

Ann Rheum Dis. 2003 Nov;62(11):1088-93.

18.

Borderline mean pulmonary artery pressure in patients with systemic sclerosis: transpulmonary gradient predicts risk of developing pulmonary hypertension.

Valerio CJ, Schreiber BE, Handler CE, Denton CP, Coghlan JG.

Arthritis Rheum. 2013 Apr;65(4):1074-84. doi: 10.1002/art.37838.

19.

Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study.

Coghlan JG, Denton CP, Grünig E, Bonderman D, Distler O, Khanna D, Müller-Ladner U, Pope JE, Vonk MC, Doelberg M, Chadha-Boreham H, Heinzl H, Rosenberg DM, McLaughlin VV, Seibold JR; DETECT study group.

Ann Rheum Dis. 2014 Jul;73(7):1340-9. doi: 10.1136/annrheumdis-2013-203301. Epub 2013 May 18.

20.

Supplemental Content

Support Center